aXichem AB Stock

AXIC A

SE0005250719

Specialty Chemicals

Market Closed - Nasdaq Stockholm 03:00:00 17/10/26 am AEDT			5-day change	1st Jan Change
1.840 ^SEK	-0.81%		-4.66%	-11.11%

14/10	Axichem Bags SEK1 Million Order for Dietary Supplements Ingredient in US	MT
27/08	AXichem AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

aXichem AB (publ) is a Sweden-based biochemical company. It develops an eco-friendly solution, Phenylcapsaicin. Phenylcapsaicin is a non-toxic antifouling agent, which can be used in the shipping industry, as it keeps vessels free from fouling. Additionally, the Company holds several world patents for alternative uses and applications of phenylcapsaicin. Phenylcapsaicin can be applied as bio-repellent against all living organisms in settings where animals cause damage to human installations. The Companyâ€™s products comprise bio-repellents, feed ingredients, food and dietary supplements, which contain synthetically produced and patented capsaicin, traded as aXiphen. The Companyâ€™s shareholders are MANAKIN LTD, BLACK ARROW LTD and LMK VENTURES AB, among others.

Employees

Sector

Specialty Chemicals

Calendar

26/11 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
17/10/26	SEK 1.840	-0.81%	16,401
15/10/26	SEK 1.855	-0.54%	42,306
14/10/26	SEK 1.865	-2.10%	64,053
13/10/26	SEK 1.905	+0.79%	64,508
12/10/26	SEK 1.890	-2.07%	97,633

Delayed Quote Nasdaq Stockholm

More quotes

Stock Market
Stocks
AXIC A Stock

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	126M 12.69M 11.28M 10.45M 9.51M 17.95M 1.2B 18.23M 49.26M 628M 47.61M 46.6M 2B	P/E 2024	-2.93x	P/E 2025	-6.9x
Enterprise Value	127M 12.85M 11.42M 10.59M 9.63M 18.18M 1.22B 18.47M 49.9M 637M 48.23M 47.21M 2.03B	EV / Sales 2024	7.67x	EV / Sales 2025	6.72x
Free-Float	82.56%	Yield 2024 *	-	Yield 2025	-

14/10	Axichem Bags SEK1 Million Order for Dietary Supplements Ingredient in US	MT
27/08	AXichem AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
26/08	Calendar Thursday, August 27	FW
25/07	AXichem's Salmonella-inhibiting Chicken Feed Additive Gets EU Agency Backing	MT
26/06	AXichem Receives Order for Feed Additives for SEK4.2 Million	MT
17/06	Axichem AB Elects Michael Engstrom As Chairman Of The Board	RE
12/06	Calendar Monday June 15 - Friday June 19	FW
22/05	Calendar Friday May 22	FW
21/05	Axichem Q1 operating loss narrows to SEK 2.8 mln	RE
21/05	AXichem AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
15/05	Axichem proposes chairman	RE
07/05	Axichem launches axiphen ruminant in Brazil	RE
09/04	AXichem: Final study report shows aXiphen improves milk production	RE

23/09	AXichem () : carries out a directed share issue in connection with the exercise of warrants of series TO2A	PU
21/09	AXichem : announces the outcome of the exercise of the warrants of series TO2A	PU
08/09	AXichem : notes growing commercial adoption in Brazil for aXiphen ruminant as Garra Nutrição increases volume to four tonnes	PU
24/08	AXichem : CEO Torsten Helsing Presents the Report for the Second Quarter 2026 in a Live Web Conference	PU
24/08	AXichem : CEO Torsten Helsing Presents the Report for the Second Quarter 2026 in a Live Web Conference	PU

1 day	-0.81%
1 week	-4.66%
Current month	-14.42%
1 month	+3.66%
3 months	-33.81%
6 months	+33.82%
Current year	-11.11%

1 week	1.81	1.98
1 month	1.72	2.31
Current year	1.14	4
1 year	1.14	4
3 years	0.9	15.5
5 years	0.9	28.3
10 years	0.9	95.8

aXichem AB Stock

Stocks

AXIC A

SE0005250719

Specialty Chemicals

Valuation: aXichem AB

Chart: aXichem AB

Latest news: aXichem AB

Press Releases: aXichem AB

Quotes and Performance

Price Extremes

Managers and Directors: aXichem AB

Latest insider transactions

Industrial Biotechnology Chemicals

Financials

Company Profile

Quotes

Manager	Title	Age	Since
Nils Torsten Helsing CEO	Chief Executive Officer	69	01/01/2016
Erik Lager COO	Chief Operating Officer	51	16/04/2025
Gunilla Savring IRC	Investor Relations Contact	64	01/01/2015

Director	Title	Age	Since
Nils Torsten Helsing CHM	Chairman	69	06/07/2007
Jan-Ove Henry Gustavsson CHM	Chairman	80	01/01/2017
Jorn Havskov Berthelsen BRD	Director/Board Member	77	01/01/2017

Date	Insider	Type	Main position	Quantity	% Market Cap.
28/3/24	Christian Mansson	Exercice	Director	33,602	0.1563%
28/3/24	Christian Mansson	Exercice	Director	134,408	0.6253%
27/3/24	Nils Torsten Helsing	Buy	Founder	200,000	0.9304%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AXICHEM AB	-0.81%	-4.66%	-33.81%	-83.12%	12.61M
ECOLAB INC.	-0.64%	+2.01%	+6.24%	+72.87%	81.52B
GIVAUDAN SA	-0.51%	+13.81%	+10.62%	+34.54%	43.79B
SIKA AG	+0.66%	+5.03%	+3.40%	-22.32%	35.07B
HENKEL AG & CO. KGAA	+1.52%	+6.12%	+11.52%	+17.38%	33.33B
NOVONESIS A/S	-0.70%	+4.53%	+11.69%	+57.64%	31.99B
FUJIFILM HOLDINGS CORPORATION	+0.94%	+0.47%	-2.14%	+16.75%	25.71B
EMS-CHEMIE HOLDING AG	0.00%	+2.02%	+56.27%	+44.06%	24.94B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-0.43%	-5.81%	+35.46%	+5.39%	17.27B
DUPONT DE NEMOURS, INC.	-0.35%	+0.52%	-44.25%	-42.15%	17.77B
Average	-0.12%	+4.06%	+5.50%	+10.10%	31.14B
Weighted average by Cap.	-0.19%	+5.03%	+9.71%	+32.00%

	2024	2025
Net sales	8.57M 865K 769K 713K 649K 1.22M 82.13M 1.24M 3.36M 42.86M 3.25M 3.18M 137M	18.45M 1.86M 1.66M 1.53M 1.4M 2.63M 177M 2.68M 7.23M 92.25M 6.99M 6.84M 294M
Net income	-17.81M -1.8M -1.6M -1.48M -1.35M -2.54M -171M -2.59M -6.98M -89.08M -6.75M -6.61M -284M	-17.63M -1.78M -1.58M -1.47M -1.33M -2.52M -169M -2.56M -6.91M -88.18M -6.68M -6.54M -281M
Net Debt	-14.36M -1.45M -1.29M -1.19M -1.09M -2.05M -138M -2.08M -5.63M -71.81M -5.44M -5.33M -229M	1.64M 166K 148K 137K 124K 235K 15.76M 239K 645K 8.22M 623K 610K 26.21M

Markets		Quality
Nasdaq Stockholm	AXIC A	Delayed
Deutsche Boerse AG	A6X	Delayed